Fighting the Uphill Battle: Current Evidence in Obesity Management
March 15, 2019
March 15, 2020
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Boston University School of Medicine and Rockpointe.
Supported by an educational grant from Novo Nordisk Inc.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
- Physicians — maximum of 1.0 AAFP Prescribed Credits
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is intended for primary care providers including family medicine, internal medicine, and other primary care clinicians who care for patients with obesity.
The current obesity epidemic shows no signs of slowing down and the factors driving it are numerous, including patient and clinician attitudes toward weight loss, a lack of clinician familiarity with guidelines, a lack of effective long-term weight-loss options, and a hesitancy among physicians to recognize obesity as a medical condition and discuss weight with their patients. Recent evidence demonstrates that primary care providers are hesitant to recommend weight-loss pharmacotherapies even in guideline-recommended settings, and many clinicians who do recommend pharmacotherapies prescribe them for too short of a course.
“Fighting the Uphill Battle: Current Evidence in Obesity Management” will provide clinicians with the latest evidence regarding obesity management in a form that can be readily integrated into practice. Clinicians will also receive real-world strategies for effectively addressing weight with their patients and initiating conversations that can begin to reverse the obesity trend that pervades society.
Upon completion of this activity, participants should be able to:
- Adopt strategies to foster effective discussions about weight loss with patients who are overweight
- Evaluate the roles and risks/benefits of behavioral and pharmacological weight-loss interventions
- Integrate guideline recommendations for assessing obesity in patients and making evidence-based recommendations for weight loss
Harold Bays MD, FOMA, FTOS, FACC, FACE, FNLA
Medical Director / President
Louisville Metabolic and Atherosclerosis Research Center
Your Body Goal
Donna Ryan, MD, FTOS
Pennington Biomedical Research Center
New Orleans, LA
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Rockpointe. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
For information about the accreditation of this program, please email: firstname.lastname@example.org.
Physician Credit Designation Statement
Boston University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Family Physicians (AAFP) Statement
This Enduring Material activity, Fighting the Uphill Battle: Current Evidence in Obesity Management, has been reviewed and is acceptable for up to 1.00 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins 3/15/2019. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
This educational activity has been produced in adherence with the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.
Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
The steering committee reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Harold Bays MD, FOMA, FTOS, FACC, FACE, FNLA
- Consultant: Amgen
- Research/Grant Support: Amgen, Eisai, Johnson & Johnson, Novo Nordisk
Donna Ryan, MD, FTOS
- Consultant: Amgen, Celtic, Epitomee, Gila Therapeutics, Janssen, KVK Tech, Novo Nordisk, Phenomix, Real Appeal, Sanofi, Scientific Intake
- Speaker: Novo Nordisk
- Stock Ownership: Epitomee, Gila Therapeutics, Phenomix, Scientific Intake
Non-faculty Content Contributors
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Caroline Apovian, MD
- Consultant: EnteroMedics, Ferring, Gelesis,Merck, Novo Nordisk, Nutrisystem, Orexigen, Sanofi-Aventis, Scientific Intake, Takeda, Zafgen
- Grant/research support: Aspire Bariatrics, Gelesis, GI Dynamics, MetaProteomics, MYOS Corporation, Orexigen, Pfizer, Takeda, The Dr. Robert C. and Veronica Atkins Foundation
- Stockholder: Science Smart LLC.
Chad Williamson, MS, MBA, CMPP; Blair St. Amand; Natalie Sanfratello; Elizabeth Drury; Brian Jack, MD (AAFP Reviewer): Nothing to disclose
Disclosure of Unlabeled Use
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
Method of Participation
There are no fees to participate in the activity. Participants must review all activity information, including the learning objectives, disclosure statements, and content. To receive credit for participation, participants must complete the post-test (achieving a passing grade) and program evaluation. Certificates can be printed immediately.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
The opinions expressed in this educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.